凯升控股(00102.HK)完成配售3亿股净筹2.97亿港元
格隆汇8月19日丨凯升控股(00102.HK)宣布,配售协议项下的所有条件已获达成及配售事项于2019年8月19日完成。合共3亿股配售股份已获配售代理根据配售协议的条款及条件按配售价每股配售股份1.01港元成功配售予不少於六名承配人。3亿股配售股份相当于公司紧接配售事项完成前已发行股本的约19.95%及公司紧随配售事项完成后已发行股本的约16.63%。
配售事项的所得款项净额为约2.97亿港元。公司拟动用所得款项净额进一步发展在俄罗斯联邦综合娱乐区的酒店及博彩业务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.